Indoco Remedies Goa Plant Clears Malta Medicines Authority Audit

Indoco Remedies Ltd. announced that its manufacturing facility for solid oral dosage form (Plant I) in Goa has successfully passed an audit by the Malta Medicines Authority. The inspection took place from November 19 to November 24, 2025. Following the audit, the facility received EU GMP certification, confirming compliance with Good Manufacturing Practice requirements as per EC Directive. Ms. Aditi Panandikar, Managing Director, stated that this approval reinforces the company's commitment to quality healthcare delivery worldwide. Indoco Remedies is an integrated pharmaceutical company with a global presence, 10 manufacturing facilities, and approvals from major regulatory authorities like USFDA and UK-MHRA.